sc13gza
 
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Novavax, Inc.
 
(Name of Issuer)
Common Stock, $0.01 par value per share
 
(Title of Class of Securities)
670002 10 4
 
(CUSIP Number)
December 31, 2008
 
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o     Rule 13d-1(b)
o     Rule 13d-1(c)
þ     Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

 


 

                     
CUSIP No.
 
670002 10 4 
13G Page  
  of   
6 Pages 

 

           
1   NAMES OF REPORTING PERSONS

Prospect Venture Partners III, L.P.
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ  (1)
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware, United States of America
       
  5   SOLE VOTING POWER
     
NUMBER OF   0 shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,169,409 shares of Common Stock (2)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0 shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    3,169,409 shares of Common Stock (2)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,169,409 shares of Common Stock (2)
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  4.58% (3)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
(1) This Schedule 13G is filed by Prospect Venture Partners III, L.P., a Delaware limited partnership (“ PVP III” ) and Prospect Management Co. III, L.L.C., a Delaware limited liability company (“PMC III,” together with PVP III, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) The shares are held by PVP III. The shares include 17,591 shares of Common Stock issuable to PVP III pursuant to an outstanding warrant exercisable January 31, 2009. PMC III serves as the general partner of PVP III, and may be deemed to own beneficially the shares held by PVP III, however PMC III owns no securities of the Issuer directly.
(3) This percentage is calculated based upon 69,169,665 shares of the Common Stock outstanding (as of October 31, 2008), as set forth in the Issuer’ s most recent Form 10-Q, filed with the Securities and Exchange Commission on November 10, 2008.


 

                     
CUSIP No.
 
670002 10 4 
13G Page  
  of   
6 Pages 

 

           
1   NAMES OF REPORTING PERSONS

Prospect Management Co. III, L.L.C.
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ (1)
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware, United States of America
       
  5   SOLE VOTING POWER
     
NUMBER OF   0 shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   3,169,409 shares of Common Stock (2)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0 shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    3,169,409 shares of Common Stock (2)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  3,169,409 shares of Common Stock (2)
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   
  4.58% (3)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO
(1) This Schedule 13G is filed by the “Reporting Persons”. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2) The shares are held by PVP III. The shares include 17,591 shares of Common Stock issuable to PVP III pursuant to an outstanding warrant exercisable January 31, 2009. PMC III serves as the general partner of PVP III, and may be deemed to own beneficially the shares held by PVP III, however PMC III owns no securities of the Issuer directly.
(3) This percentage is calculated based upon 69,169,665 shares of the Common Stock outstanding (as of October 31, 2008), as set forth in the Issuer ’ s most recent Form 10-Q, filed with the Securities and Exchange Commission on November 10, 2008.


 

     
Item 1(a).
  Name of Issuer:
 
   
 
  Novavax, Inc.
     
Item 1(b).
  Address of Issuer’s Principal Executive Offices:
 
   
 
  9920 Belward Campus Drive
 
  Rockville, Maryland 20850
     
Item 2(a).
  Name of Person Filing:
 
   
 
 
          Prospect Venture Partners III, L.P. (“PVP III”)
 
 
          Prospect Management Co. III, L.L.C. (“PMC III”)
     
Item 2(b).
  Address of Principal Business Office or, if none, Residence:
 
 
  c/o Prospect Venture Partners
 
  435 Tasso Street, Suite 200
 
  Palo Alto, California 94301
     
Item 2(c).
  Citizenship:
 
   
 
                 PVP III — Delaware, United States of America
 
                 PMC III — Delaware, United States of America
     
Item 2(d).
  Title of Class of Securities:
 
   
 
  Common Stock
     
Item 2(e).
  CUSIP Number:
 
   
 
  670002 10 4
     
Item 3.
  Not applicable.
Item 4. Ownership. The following information with respect to the ownership of the Common Stock of the Issuer by the Reporting Persons filing this Amendment No. 2 to the statement on Schedule 13G is provided as of December 31, 2008:
                                                                 
            Warrants           Shared   Sole   Shared        
    Shares Held   Held   Sole Voting   Voting   Dispositive   Dispositive   Beneficial   Percentage
Reporting Persons   Directly   Directly   Power   Power (1)   Power   Power (1)   Ownership (1)   of Class (2)
PVP III
    3,151,818       17,591       0       3,169,409       0       3,169,409       3,169,409       4.58 %
 
PMC III
    0       0       0       3,169,409       0       3,169,409       3,169,409       4.58 %
 
(1)   PMC III serves as the general partner of PVP III, and may be deemed to own beneficially the shares held by PVP III, however PMC III owns no securities of the Issuer directly.
 
(2)   This percentage is calculated based upon 69,169,665 shares of the Common Stock outstanding (as of October 31, 2008), as set forth in the Issuer’s most recent Form 10-Q, filed with the Securities and Exchange Commission on November 10, 2008.
Item 5. Ownership of 5 Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following x.
Item 6. Ownership of More than 5 Percent on Behalf of Another Person
     Not applicable.

Page 4 of 6 Pages


 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
     Not applicable.
Item 8. Identification and Classification of Members of the Group
     Not applicable.
Item 9. Notice of Dissolution of a Group
     Not applicable.
Item 10. Certification
     Not applicable.

Page 5 of 6 Pages


 

SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 11, 2009
PROSPECT VENTURE PARTNERS III, L.P.
     
By:
  Prospect Management Co. III, L.L.C.
Its:
  General Partner
     
/s/ Dave Markland
   
 
   
Dave Markland
   
Attorney-in-Fact
   
PROSPECT MANAGEMENT CO. III, L.L.C.
     
/s/ Dave Markland
   
 
   
Dave Markland
Attorney-in-Fact
   
Attention:   Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Page 6 of 6 Pages